Creative Medical Technology Holdings, Inc.
CELZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001187953
No open-market purchases or sales by Creative Medical Technology Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $540.7K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Creative Medical Technology Holdings, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 11 | 12 | +1 |
| Shares | 201.6K | 69.9K | −131.6K (−65.3%) |
| Value | $437.1K | $185.4K | −$251.7K (−57.6%) |
New holders (4)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northern Trust Corp | 11,707 | $31.0K | 0.00% |
| Citadel Advisors LLC | 11,145 | $29.5K | 0.00% |
| Allworth Financial LP | 4,000 | $10.6K | 0.00% |
| Ameritas Advisory Services, LLC | 2,276 | $6.03K | 0.00% |
Sold out (3)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Armistice Capital, LLC | 148,000 | $321.2K |
| HRT Financial LP | 13,053 | $28.0K |
| ORG Partners LLC | 80 | $160 |